Medical Care
Global Artificial Intelligence (AI) in Cancer Market Research Report 2025
- Jul 08, 25
- ID: 349352
- Pages: 85
- Figures: 81
- Views: 11
The global market for Artificial Intelligence (AI) in Cancer was valued at US$ 1797 million in the year 2024 and is projected to reach a revised size of US$ 2849 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
AI algorithms are being developed to analyze medical imaging data such as mammograms, CT scans, and pathology slides to aid in the early detection and diagnosis of cancer. AI"s ability to analyze large datasets quickly can assist healthcare professionals in identifying potential signs of cancer at an early, more treatable stage.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Cancer.
The Artificial Intelligence (AI) in Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence (AI) in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
AI algorithms are being developed to analyze medical imaging data such as mammograms, CT scans, and pathology slides to aid in the early detection and diagnosis of cancer. AI"s ability to analyze large datasets quickly can assist healthcare professionals in identifying potential signs of cancer at an early, more treatable stage.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Cancer.
The Artificial Intelligence (AI) in Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence (AI) in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2020-2031)
2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Cancer Revenue
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2024
3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
6.2 North America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
9.2 Latin America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.1.5 IBM Recent Development
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.2.5 Microsoft Recent Development
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.3.5 NVIDIA Recent Development
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.7.5 Cancer Center.ai Recent Development
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.8.5 Digital Reasoning Recent Development
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.9.5 Varian Medical Systems Recent Development
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.10.5 Niramai Recent Development
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.11.5 Densitas Recent Development
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.12.5 MammoScreen Recent Development
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.13.5 MVision AI Recent Development
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.14.5 Volpara Recent Development
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.15.5 LungLifeAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2020-2031)
2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Cancer Revenue
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2024
3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
6.2 North America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
9.2 Latin America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.1.5 IBM Recent Development
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.2.5 Microsoft Recent Development
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.3.5 NVIDIA Recent Development
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.7.5 Cancer Center.ai Recent Development
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.8.5 Digital Reasoning Recent Development
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.9.5 Varian Medical Systems Recent Development
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.10.5 Niramai Recent Development
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.11.5 Densitas Recent Development
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.12.5 MammoScreen Recent Development
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.13.5 MVision AI Recent Development
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.14.5 Volpara Recent Development
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025)
11.15.5 LungLifeAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Phototherapy
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Sonodynamic Therapy
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2020-2025)
Table 13. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2026-2031)
Table 15. Artificial Intelligence (AI) in Cancer Market Trends
Table 16. Artificial Intelligence (AI) in Cancer Market Drivers
Table 17. Artificial Intelligence (AI) in Cancer Market Challenges
Table 18. Artificial Intelligence (AI) in Cancer Market Restraints
Table 19. Global Artificial Intelligence (AI) in Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Artificial Intelligence (AI) in Cancer Market Share by Players (2020-2025)
Table 21. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2024)
Table 22. Ranking of Global Top Artificial Intelligence (AI) in Cancer Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Artificial Intelligence (AI) in Cancer, Headquarters and Area Served
Table 25. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 26. Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2020-2025)
Table 30. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2026-2031)
Table 32. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2020-2025)
Table 34. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2026-2031)
Table 36. North America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 51. IBM Company Details
Table 52. IBM Business Overview
Table 53. IBM Artificial Intelligence (AI) in Cancer Product
Table 54. IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 55. IBM Recent Development
Table 56. Microsoft Company Details
Table 57. Microsoft Business Overview
Table 58. Microsoft Artificial Intelligence (AI) in Cancer Product
Table 59. Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 60. Microsoft Recent Development
Table 61. NVIDIA Company Details
Table 62. NVIDIA Business Overview
Table 63. NVIDIA Artificial Intelligence (AI) in Cancer Product
Table 64. NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 65. NVIDIA Recent Development
Table 66. Intel Company Details
Table 67. Intel Business Overview
Table 68. Intel Artificial Intelligence (AI) in Cancer Product
Table 69. Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 70. Intel Recent Development
Table 71. GE Healthcare Company Details
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Artificial Intelligence (AI) in Cancer Product
Table 74. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product
Table 79. Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Cancer Center.ai Company Details
Table 82. Cancer Center.ai Business Overview
Table 83. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product
Table 84. Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 85. Cancer Center.ai Recent Development
Table 86. Digital Reasoning Company Details
Table 87. Digital Reasoning Business Overview
Table 88. Digital Reasoning Artificial Intelligence (AI) in Cancer Product
Table 89. Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 90. Digital Reasoning Recent Development
Table 91. Varian Medical Systems Company Details
Table 92. Varian Medical Systems Business Overview
Table 93. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product
Table 94. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 95. Varian Medical Systems Recent Development
Table 96. Niramai Company Details
Table 97. Niramai Business Overview
Table 98. Niramai Artificial Intelligence (AI) in Cancer Product
Table 99. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 100. Niramai Recent Development
Table 101. Densitas Company Details
Table 102. Densitas Business Overview
Table 103. Densitas Artificial Intelligence (AI) in Cancer Product
Table 104. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 105. Densitas Recent Development
Table 106. MammoScreen Company Details
Table 107. MammoScreen Business Overview
Table 108. MammoScreen Artificial Intelligence (AI) in Cancer Product
Table 109. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 110. MammoScreen Recent Development
Table 111. MVision AI Company Details
Table 112. MVision AI Business Overview
Table 113. MVision AI Artificial Intelligence (AI) in Cancer Product
Table 114. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 115. MVision AI Recent Development
Table 116. Volpara Company Details
Table 117. Volpara Business Overview
Table 118. Volpara Artificial Intelligence (AI) in Cancer Product
Table 119. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 120. Volpara Recent Development
Table 121. LungLifeAI Company Details
Table 122. LungLifeAI Business Overview
Table 123. LungLifeAI Artificial Intelligence (AI) in Cancer Product
Table 124. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 125. LungLifeAI Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Artificial Intelligence (AI) in Cancer Picture
Figure 2. Global Artificial Intelligence (AI) in Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2024 VS 2031
Figure 4. Surgery Features
Figure 5. Radiotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Immunotherapy Features
Figure 8. Phototherapy Features
Figure 9. Gene Therapy Features
Figure 10. Sonodynamic Therapy Features
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2024 VS 2031
Figure 13. Diagnosis Case Studies
Figure 14. Therapy Case Studies
Figure 15. Prognosis Case Studies
Figure 16. Health Management Case Studies
Figure 17. Research Case Studies
Figure 18. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 19. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Artificial Intelligence (AI) in Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Artificial Intelligence (AI) in Cancer Market Share by Region: 2024 VS 2031
Figure 22. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2024
Figure 23. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2024
Figure 25. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 27. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 31. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Region (2020-2031)
Figure 39. China Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 47. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 51. Turkey Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. IBM Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 55. Microsoft Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 56. NVIDIA Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 57. Intel Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 59. Johnson & Johnson Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 60. Cancer Center.ai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 61. Digital Reasoning Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 62. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 63. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 64. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 65. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 66. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 67. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 68. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Phototherapy
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Sonodynamic Therapy
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2020-2025)
Table 13. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2026-2031)
Table 15. Artificial Intelligence (AI) in Cancer Market Trends
Table 16. Artificial Intelligence (AI) in Cancer Market Drivers
Table 17. Artificial Intelligence (AI) in Cancer Market Challenges
Table 18. Artificial Intelligence (AI) in Cancer Market Restraints
Table 19. Global Artificial Intelligence (AI) in Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Artificial Intelligence (AI) in Cancer Market Share by Players (2020-2025)
Table 21. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2024)
Table 22. Ranking of Global Top Artificial Intelligence (AI) in Cancer Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Artificial Intelligence (AI) in Cancer, Headquarters and Area Served
Table 25. Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
Table 26. Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2020-2025)
Table 30. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2026-2031)
Table 32. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2020-2025)
Table 34. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2026-2031)
Table 36. North America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 51. IBM Company Details
Table 52. IBM Business Overview
Table 53. IBM Artificial Intelligence (AI) in Cancer Product
Table 54. IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 55. IBM Recent Development
Table 56. Microsoft Company Details
Table 57. Microsoft Business Overview
Table 58. Microsoft Artificial Intelligence (AI) in Cancer Product
Table 59. Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 60. Microsoft Recent Development
Table 61. NVIDIA Company Details
Table 62. NVIDIA Business Overview
Table 63. NVIDIA Artificial Intelligence (AI) in Cancer Product
Table 64. NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 65. NVIDIA Recent Development
Table 66. Intel Company Details
Table 67. Intel Business Overview
Table 68. Intel Artificial Intelligence (AI) in Cancer Product
Table 69. Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 70. Intel Recent Development
Table 71. GE Healthcare Company Details
Table 72. GE Healthcare Business Overview
Table 73. GE Healthcare Artificial Intelligence (AI) in Cancer Product
Table 74. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 75. GE Healthcare Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product
Table 79. Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Cancer Center.ai Company Details
Table 82. Cancer Center.ai Business Overview
Table 83. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product
Table 84. Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 85. Cancer Center.ai Recent Development
Table 86. Digital Reasoning Company Details
Table 87. Digital Reasoning Business Overview
Table 88. Digital Reasoning Artificial Intelligence (AI) in Cancer Product
Table 89. Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 90. Digital Reasoning Recent Development
Table 91. Varian Medical Systems Company Details
Table 92. Varian Medical Systems Business Overview
Table 93. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product
Table 94. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 95. Varian Medical Systems Recent Development
Table 96. Niramai Company Details
Table 97. Niramai Business Overview
Table 98. Niramai Artificial Intelligence (AI) in Cancer Product
Table 99. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 100. Niramai Recent Development
Table 101. Densitas Company Details
Table 102. Densitas Business Overview
Table 103. Densitas Artificial Intelligence (AI) in Cancer Product
Table 104. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 105. Densitas Recent Development
Table 106. MammoScreen Company Details
Table 107. MammoScreen Business Overview
Table 108. MammoScreen Artificial Intelligence (AI) in Cancer Product
Table 109. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 110. MammoScreen Recent Development
Table 111. MVision AI Company Details
Table 112. MVision AI Business Overview
Table 113. MVision AI Artificial Intelligence (AI) in Cancer Product
Table 114. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 115. MVision AI Recent Development
Table 116. Volpara Company Details
Table 117. Volpara Business Overview
Table 118. Volpara Artificial Intelligence (AI) in Cancer Product
Table 119. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 120. Volpara Recent Development
Table 121. LungLifeAI Company Details
Table 122. LungLifeAI Business Overview
Table 123. LungLifeAI Artificial Intelligence (AI) in Cancer Product
Table 124. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2020-2025) & (US$ Million)
Table 125. LungLifeAI Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Artificial Intelligence (AI) in Cancer Picture
Figure 2. Global Artificial Intelligence (AI) in Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2024 VS 2031
Figure 4. Surgery Features
Figure 5. Radiotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Immunotherapy Features
Figure 8. Phototherapy Features
Figure 9. Gene Therapy Features
Figure 10. Sonodynamic Therapy Features
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2024 VS 2031
Figure 13. Diagnosis Case Studies
Figure 14. Therapy Case Studies
Figure 15. Prognosis Case Studies
Figure 16. Health Management Case Studies
Figure 17. Research Case Studies
Figure 18. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 19. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Artificial Intelligence (AI) in Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Artificial Intelligence (AI) in Cancer Market Share by Region: 2024 VS 2031
Figure 22. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2024
Figure 23. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2024
Figure 25. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 27. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 31. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Region (2020-2031)
Figure 39. China Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 47. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Country (2020-2031)
Figure 51. Turkey Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. IBM Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 55. Microsoft Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 56. NVIDIA Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 57. Intel Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 59. Johnson & Johnson Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 60. Cancer Center.ai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 61. Digital Reasoning Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 62. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 63. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 64. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 65. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 66. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 67. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 68. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Anti-counterfeit Clothing and Accessories Packaging Market Research Report 2025
Aug 30, 25
Global Animal Vaccines Market Research Report 2025
Aug 30, 25
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Research Report 2025
Aug 30, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232